Literature DB >> 20071249

Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis.

Charles R Esther1, Denise A Esserman, Peter Gilligan, Alan Kerr, Peadar G Noone.   

Abstract

BACKGROUND: Although nontuberculous mycobacteria (NTM) are recognized pathogens in cystic fibrosis (CF), associations with clinical outcomes remain unclear.
METHODS: Microbiological data was obtained from 1216 CF patients over 8years (481+/-55patients/year). Relationships to clinical outcomes were examined in the subset (n=271, 203+/-23 patients/year) with longitudinal data.
RESULTS: Five hundred thirty-six of 4862 (11%) acid-fast bacilli (AFB) cultures grew NTM, with Mycobacterium abscessus (n=298, 55.6%) and Mycobacterium avium complex (n=190, 35.4%) most common. Associated bacterial cultures grew Stenotrophomonas or Aspergillus species more often when NTM were isolated (18.2% vs. 8.4% and 13.9% vs. 7.2%, respectively, p<0.01). After controlling for confounders, patients with chronic M. abscessus infection had greater rates of lung function decline than those with no NTM infection (-2.52 vs. -1.64% predicted FEV(1)/year, p<0.05).
CONCLUSIONS: NTM infection is common in CF and associated with particular pathogens. Chronic M. abscessus infection is associated with increased lung function decline. Copyright (c) 2009 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20071249      PMCID: PMC3837580          DOI: 10.1016/j.jcf.2009.12.001

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  20 in total

Review 1.  Emergence of nontuberculous mycobacteria as pathogens in cystic fibrosis.

Authors:  David E Griffith
Journal:  Am J Respir Crit Care Med       Date:  2003-03-15       Impact factor: 21.405

Review 2.  Nontuberculous mycobacteria in cystic fibrosis.

Authors:  Samiya Razvi; Samiya Ravzi; Lisa Saiman
Journal:  Pediatr Infect Dis J       Date:  2007-03       Impact factor: 2.129

3.  Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease.

Authors:  Kenneth N Olivier; David J Weber; Ji-Hyun Lee; Allison Handler; Gail Tudor; Paul L Molina; Joseph Tomashefski; Michael R Knowles
Journal:  Am J Respir Crit Care Med       Date:  2002-11-14       Impact factor: 21.405

4.  Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.

Authors:  Kenneth N Olivier; David J Weber; Richard J Wallace; Ali R Faiz; Ji-Hyun Lee; Yansheng Zhang; Barbara A Brown-Elliot; Allison Handler; Rebecca W Wilson; Michael S Schechter; Lloyd J Edwards; Subha Chakraborti; Michael R Knowles
Journal:  Am J Respir Crit Care Med       Date:  2002-11-14       Impact factor: 21.405

Review 5.  Diagnosis and treatment of infections caused by rapidly growing mycobacteria.

Authors:  Rhonda E Colombo; Kenneth N Olivier
Journal:  Semin Respir Crit Care Med       Date:  2008-09-22       Impact factor: 3.119

6.  Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis.

Authors:  S Whittier; R L Hopfer; M R Knowles; P H Gilligan
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

7.  Atypical mycobacterial infection in patients with cystic fibrosis: update on clinical microbiology methods.

Authors:  P W Jordan; T Stanley; F M Donnelly; J S Elborn; R B McClurg; B C Millar; C E Goldsmith; J E Moore
Journal:  Lett Appl Microbiol       Date:  2007-05       Impact factor: 2.858

8.  [Nontuberculous mycobacterial infection in patients with cystic fibrosis: a multicenter prevalence study].

Authors:  Rosa M Girón; Luis Máiz; Isabel Barrio; M Teresa Martínez; Antonio Salcedo; Concepción Prados
Journal:  Arch Bronconeumol       Date:  2008-12       Impact factor: 4.872

Review 9.  The natural history of nontuberculous mycobacteria in patients with cystic fibrosis.

Authors:  Kenneth N Olivier
Journal:  Paediatr Respir Rev       Date:  2004       Impact factor: 2.726

10.  Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel.

Authors:  Isaac Levy; Galia Grisaru-Soen; Liat Lerner-Geva; Eitan Kerem; Hana Blau; Lea Bentur; Micha Aviram; Joseph Rivlin; Elie Picard; Anita Lavy; Yakov Yahav; Galia Rahav
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

View more
  129 in total

1.  Molecular fingerprinting of Mycobacterium abscessus strains in a cohort of pediatric cystic fibrosis patients.

Authors:  Kathryn A Harris; Dervla T D Kenna; Cornelis Blauwendraat; John C Hartley; Jane F Turton; Paul Aurora; Garth L J Dixon
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

Review 2.  Non-tuberculous mycobacteria in cystic fibrosis.

Authors:  Uta G Hill; R Andres Floto; Charles S Haworth
Journal:  J R Soc Med       Date:  2012-06       Impact factor: 5.344

3.  Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.

Authors:  Valerie Waters; Felix Ratjen
Journal:  Cochrane Database Syst Rev       Date:  2020-06-10

4.  Whole-Genome Sequencing for Predicting Clarithromycin Resistance in Mycobacterium abscessus.

Authors:  Samuel Lipworth; Natasha Hough; Laura Leach; Marcus Morgan; Katie Jeffery; Monique Andersson; Esther Robinson; E Grace Smith; Derrick Crook; Tim Peto; Timothy Walker
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

5.  β-Lactam Combinations That Exhibit Synergy against Mycobacteroides abscessus Clinical Isolates.

Authors:  Elizabeth Story-Roller; Christos Galanis; Gyanu Lamichhane
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

6.  Detection of rapidly growing mycobacteria in routine cultures of samples from patients with cystic fibrosis.

Authors:  Charles R Esther; Steven Hoberman; Jason Fine; Sonia Allen; Karissa Culbreath; Kyle Rodino; Alan Kerr; Peter Gilligan
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

Review 7.  Is bronchoscopy an obsolete tool in cystic fibrosis? The role of bronchoscopy in cystic fibrosis and its clinical use.

Authors:  Lisa Paul
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

Review 8.  Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.

Authors:  Janice M Leung; Kenneth N Olivier
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

Review 9.  The Evolution of Cystic Fibrosis Care.

Authors:  Jessica E Pittman; Thomas W Ferkol
Journal:  Chest       Date:  2015-08       Impact factor: 9.410

Review 10.  Autophagy in Pulmonary Diseases.

Authors:  Kiichi Nakahira; Maria Angelica Pabon Porras; Augustine M K Choi
Journal:  Am J Respir Crit Care Med       Date:  2016-11-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.